Approved uses
The source catalogue does not contain complete approved indications. Ask for the current approved product literature and have a qualified healthcare professional confirm suitability.
A tablet combining levocetirizine and montelukast in the strengths shown in the catalogue.
Levocetirizine dihydrochloride 5 mg + Montelukast 10 mg

Product overview
A tablet combining levocetirizine and montelukast in the strengths shown in the catalogue.
Letzy-M is presented in the allergy & respiratory care section of our portfolio. This page brings together its labelled ingredients, dosage form and original catalogue artwork, so healthcare professionals and business partners can review the available information in one place.
Composition
The following details are shown in the retained product artwork.
Full excipients, serving basis, release specification and any ingredient quantities not stated in the artwork should be confirmed from the current approved pack. Different presentations of a brand are not automatically interchangeable.
Product label & presentation
Review the retained catalogue artwork. Open any label at full size to inspect the source information.
Request pack sizes, approved literature, product availability and commercial information for Letzy-M.
Use, storage & suitability
The source catalogue does not contain complete approved indications. Ask for the current approved product literature and have a qualified healthcare professional confirm suitability.
Follow the current label and the instructions given by your healthcare professional. A labelled ingredient strength is not a recommended daily dose.
Ask your doctor or pharmacist to review allergies, other medicines, supplements, pregnancy or breastfeeding, and relevant medical conditions before use.
Follow the storage conditions on the current pack, including any temperature or light restrictions. Check the expiry date and keep products away from children.
This reference concerns an ingredient. It does not verify or replace the approved literature for this Spark product.
Product questions
A tablet combining levocetirizine and montelukast in the strengths shown in the catalogue.
Levocetirizine dihydrochloride 5 mg; Montelukast 10 mg. These details are transcribed from the supplied catalogue artwork. Check the current approved label for the complete formula and excipients.
The amount, frequency and duration should come from the current approved label and your healthcare professional. The strengths shown on this page describe the product; they are not dosing instructions.
Send a product enquiry mentioning Letzy-M. Our team can confirm the current pack, availability, commercial terms and approved product literature.
Yes. Share your city, state and business requirements in a partnership enquiry. Territory availability and commercial terms are confirmed by the Spark Healthcare team.
Let’s take the next step
Talk to us about Letzy-M, current specifications or a potential partnership.
Enquire about Letzy-M